Atrial Septal Defect Device Closure in Patients with Metabolic Diseases
or Genetic Syndromes
- Keyhan Sayadpour Zanjani,
- Morteza Heidari,
- Nima Nazari,
- Reihaneh Mohsenipour
Keyhan Sayadpour Zanjani
Tehran University of Medical Sciences
Corresponding Author:ksayadpour@gmail.com
Author ProfileReihaneh Mohsenipour
Tehran University of Medical Sciences
Author ProfileAbstract
Concomitant metabolic or genetic syndromes can make atrial septal defect
device closure difficult. We searched our database and found eight. The
cohort consists of patients with different metabolic and genetic disease
. Thromboembolic events and device embolization occurred in some
patients. Careful attention is recommended in patients with special
diseases.